Targeted Cancer Therapies Congress 2010
date: 21-23 September 2010
topic: targeted cancer therapies
organizer: Terrapinn
location: Zurich
Over 30 sessions devoted to improving pre-clinical and early clinical development for the acceleration of products into the marketplace: strategic and scientific exchange concerning oncology biomarkers, diagnostics, target discovery and validation, pre-clinical models and clinical trial design.
Unrivalled involvement from pharma and biotech with the biggest players in the oncology marketplace participating: Key representation from Roche, Novartis, Biogen Idec, ImClone Systems, Merck Serono, Merck & Co, Abbott Laboratories, Pfizer, AstraZeneca, Human Genome Sciences and many more…
Visit our website for more information: www.terrapinn.com/2010/tct